Bluejay Diagnostics (BJDX) Other Operating Expenses (2020 - 2024)
Bluejay Diagnostics (BJDX) reported Other Operating Expenses of $816.0 for Q4 2024, up 18.78% on a YoY basis from $687.0 in Q1 2024, and up 8.37% sequentially from $753.0 in Q3 2024.
Bluejay Diagnostics (BJDX) Other Operating Expenses (2020 - 2024) Analysis & Trends
Bluejay Diagnostics (BJDX) has 5 years of Other Operating Expenses data on file, last reported at $816.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses rose 18.78% year-over-year to $816.0; the trailing twelve-month figure through Sep 2025 stood at $816.0 (down 90.01% YoY), and the FY2024 full-year result was $8297.0, down 97.07% from the prior year.
- Other Operating Expenses climbed to $816.0 in Q4 2024, from $753.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.2 million in Q1 2023 to a low of -$210117.0 in Q3 2022.
- A 5-year average of $173751.8 and a median of $15303.5 in 2021 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses soared 2824.45% in 2021 and plunged 398.42% in 2022, its largest moves.
- Tracing BJDX's Other Operating Expenses over 5 years: stood at -$35170.0 in 2020, then soared by 2824.45% to $958190.0 in 2021, then slumped by 82.23% to $170277.0 in 2022, then plunged by 99.6% to $687.0 in 2023, then increased by 18.78% to $816.0 in 2024.
- Business Quant data shows BJDX's Other Operating Expenses at $816.0 in Q4 2024, $753.0 in Q3 2024, and $305.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 816.00 |
| Sep 30, 2024 | 753.00 |
| Jun 30, 2024 | 305.00 |
| Mar 31, 2024 | 6,424.00 |
| Dec 31, 2023 | 687.00 |
| Sep 30, 2023 | -19,619.00 |
| Jun 30, 2023 | 154,329.00 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 170,277.00 |
| Sep 30, 2022 | -210,117.00 |
| Jun 30, 2022 | 81,357.00 |
| Mar 31, 2022 | 694,757.00 |
| Dec 31, 2021 | 958,190.00 |
| Sep 30, 2021 | 70,411.00 |
| Jun 30, 2021 | 50,250.00 |
| Mar 31, 2021 | 24,183.00 |
| Dec 31, 2020 | -35,170.00 |
| Sep 30, 2020 | 2,723.00 |